October 13, 2025

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 21% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, has garnered significant attention from investors, and for compelling reasons. With a market..

Regeneron Pharmaceuticals (REGN) Stock Analysis: A 27.79% Upside Beckons Investors Amidst Biotechnology Innovations

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a heavyweight in the biotechnology sector, offers a compelling narrative for investors seeking exposure to groundbreaking medical innovations. With a market..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 31% Upside Potential in Transforming Organ Transplantation

TransMedics Group, Inc. (NASDAQ: TMDX), a prominent player in the healthcare sector, is pioneering advancements in organ transplant therapy. With a current market capitalization of $3.66..

Teva Pharmaceutical Industries (TEVA) Rating Update: Assessing a Strong Buy Consensus Amidst a 22% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare arena, has long been a critical player in the specialty and generic drug manufacturing sector...

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a 19.97% Potential Upside for Savvy Investors

Stevanato Group S.p.A. (NYSE: STVN) is making waves in the healthcare sector, particularly in the Medical Instruments & Supplies industry. This Italy-based company, with a robust..

Insulet Corporation (PODD) Stock Analysis: Exploring a 15.3% Potential Upside with Robust Growth Prospects

Investors looking to capitalize on the growing demand for innovative medical devices might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect. With a market capitalization of..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Exploring a 7.67% Potential Upside Amidst Strong Buy Ratings

For investors with an eye on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) presents an intriguing opportunity, especially given the company’s dominant presence in the..

ResMed Inc. (RMD) Stock Analysis: Navigating a 7.83% Potential Upside Amid Healthcare Innovation

ResMed Inc. (NYSE: RMD), a prominent player in the Healthcare sector, operates within the Medical Instruments & Supplies industry, offering a robust portfolio of medical devices..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 10% Upside Potential in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN), a global leader in molecular diagnostics and research, offers investors an intriguing opportunity with a potential upside of 10.54%, according to current..

Gilead Sciences (GILD) Stock Analysis: Evaluating a 7.79% Upside Potential in the Healthcare Sector

Gilead Sciences, Inc. (NASDAQ: GILD), a leading player in the healthcare sector, has been at the forefront of biopharmaceutical innovation, particularly in areas of unmet medical..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring the 15.28% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands out as a powerhouse in the healthcare sector. With a commanding market capitalization of $37.27 billion, the company is a..

Masimo Corporation (MASI) Stock Analysis: Exploring a 29.68% Potential Upside in Healthcare Innovation

Masimo Corporation (NASDAQ: MASI) is a significant player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $7.86 billion, Masimo..

Quest Diagnostics (DGX) Stock Analysis: Unveiling a 3.05% Potential Upside in the Healthcare Sector

Investors keeping an eye on the healthcare sector would do well to examine Quest Diagnostics Incorporated (NYSE: DGX), a significant player in the diagnostics and research..

Globus Medical, Inc. (GMED) Stock Analysis: 40% Potential Upside in the Healthcare Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. With a..

Alkermes plc (ALKS) Stock Analysis: Investor Outlook with a 33.82% Potential Upside

For investors seeking opportunities in the healthcare sector, Alkermes plc (NASDAQ: ALKS) presents a compelling case. This Dublin-based biopharmaceutical company stands out with its focus on..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Promising 143% Upside Potential for Biotech Investors

Vaxcyte, Inc. (NASDAQ: PCVX) has emerged as a focal point for investors seeking high-growth opportunities in the biotechnology sector. With its cutting-edge approach to vaccine development,..

Verona Pharma plc (VRNA) Stock Report: Evaluating the Potential of a Biotech Powerhouse with a $9.09 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a prominent player in the healthcare sector, is capturing investor attention with its substantial $9.09 billion market capitalization. As a biopharmaceutical..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 82.87% Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out in the biotechnology industry, promising significant growth potential amid its innovative therapeutic developments. The company, headquartered in Redwood City,..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 17.34% Potential Upside Amidst Healthcare Sector Dynamics

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is capturing investor attention with its significant market presence and a potential upside of 17.34%,..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant’s Robust Growth and Strategic Positioning

Cencora, Inc. (NYSE: COR), a key player in the healthcare sector, has recently undergone significant changes that could position it for robust growth. Formerly known as..

Search

Funds

October 13, 2025

Search

Funds

October 13, 2025

FTSE 100

Funds